Last week, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes accompanied by multiple interviews with our management team. This interview with our CCO, Damien Perriman, focuses on the commercialization of our platform.

Perriman states: "We're moving really quick, like things that I would expect a year to take, we're doing in weeks. That kind of blew my socks off and I started speaking to some of my colleagues, asking what if we could actually move a proof of concept so much faster than we did before? What does that mean for the type of partnerships that we could create? Or could we engage partners much sooner in the equation than we did before?"

Full interview is available here:

[link]

#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport